CD274 and neoplasm: The cGAMP-NPs decreased the melanoma tumor burden (with a restricted responsiveness to anti-PD-L1) and impelled intrinsic and adaptive host-protected responses to existing tumors in orthotopic and genetically engineered patterns of basal-like TNBC.